Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02470754 · ClinicalTrials.gov registry record · NA
Clinical Pharmacology of Electronic Cigarettes
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT02470754 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 38 participants.
The verdict
NCT02470754, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about nicotine exposure and the safety of electronic cigarettes (EC). It will focus on the areas that are thought to most closely relate to the addictive potential of EC, namely: (1) EC as nicotine delivery devices, covering issues of nicotine intake and pharmacokinetics, temporal patterns of use and titration of nicotine; and (2) subjective effects of EC use, including relationship of use to reward, withdrawal and craving.
Interventions
- DEVICE Electronic Cigarette
- DEVICE Tobacco Cigarette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2015-07-23 |
| Est. Completion | 2018-02-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02470754
The ClinicalTrials.gov registry entry for NCT02470754 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Electronic Cigarette is the first listed.
NCT02470754 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02470754 about?
NCT02470754 is a clinical study titled "Clinical Pharmacology of Electronic Cigarettes". The purpose of this study is to learn more about nicotine exposure and the safety of electronic cigarettes (EC). It will focus on the areas that are thought to most closely relate to the addictive potential of EC, namely: (1) EC as nicotine delivery devices, covering issues of nicotine intake and ph...
What is the current status of trial NCT02470754?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2015-07-23. Estimated completion is 2018-02-02.
What interventions are being tested in trial NCT02470754?
The interventions under investigation include: Electronic Cigarette (DEVICE), Tobacco Cigarette (DEVICE).
Who is sponsoring clinical trial NCT02470754?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.